Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) — Cash Flow Reinvestment Rate

Latest as of December 2024: 3.98x

Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has a Cash Flow Reinvestment Rate of 3.98x as of December 2024, reinvesting CN¥503.43 Million (capex CN¥115.96 Million plus investments CN¥-387.47 Million) from operating cash flow of CN¥126.49 Million. Explore Jiangsu Canopus Wisdom Medical Technolog (301290) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

3.98x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥503.43 Million
Capex + Investments

Operating Cash Flow

CN¥126.49 Million
CNY

Capital Expenditures

CN¥115.96 Million
CNY

Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Cash Flow Reinvestment Rate (2020–2024)

Historical reinvestment intensity for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A across 5 annual periods. Also explore total assets of Jiangsu Canopus Wisdom Medical Technolog for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)

Year-by-year capital reinvestment analysis for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A. For live market cap and broader valuation context, see market value of Jiangsu Canopus Wisdom Medical Technolog.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 3.98x CN¥503.43 Million CN¥126.49 Million CN¥115.96 Million ▲ +2.0%
2023 3.90x CN¥636.51 Million CN¥163.13 Million CN¥111.46 Million ▲ +162.4%
2022 1.49x CN¥140.72 Million CN¥94.63 Million CN¥74.35 Million ▲ +142.4%
2021 0.61x CN¥100.25 Million CN¥163.45 Million CN¥95.67 Million ▼ -76.8%
2020 2.64x CN¥301.35 Million CN¥114.07 Million CN¥25.43 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow